Avenue Therapeutics Inc

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. Show More...

  • Website https://www.avenuetx.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 0.24 USD
  • Last Updated 29-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -0.36 -1.85 -2.1 -1.65 -0.91
    Dividends USD
    Payout Ratio % *
    Shares Mil 9.0 7.0 10.0 16.0 16.0
    Book Value Per Share * USD 2.36 0.26 0.71 0.34
    Free Cash Flow Per Share * USD -0.25 -2.09 -1.35
    Return on Assets % -109.61 -161.44 -385.54 -87.12
    Financial Leverage (Average) 1.14 1.31 1.16
    Return on Equity % -220.23 -229.86 -839.94 -121.58
    Return on Invested Capital % -215.07 -230.85 -851.52 -123.86
    Interest Coverage -4.19 -31.68
    Current Ratio 0.03 7.95 0.88 4.22 7.25
    Quick Ratio 0.03 7.81 0.52 4.13 7.12
    Debt/Equity